| CASE REPORT |
|
| Year : 2018 | Volume
: 10
| Issue : 4 | Page : 141-144 |
|
|
Successful use of a combination of two long-acting basal insulin analogs for the treatment of marked insulin resistance in type 2 diabetes unresponsive to standard therapy
Kamal Abouglila
Diabetes Centre, University Hospital of North Durham, Durham, UK
Correspondence Address:
Dr. Kamal Abouglila
Diabetes Centre, University Hospital of North Durham, Durham
UK
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijmbs.ijmbs_20_18
|
|
|
Insulin resistance is a major management challenge in patients with Type 2 diabetes (T2DM). A 62-year-old female patient with T2DM caused by insulin resistance is reported. Her hyperglycemia did not respond to conventional combinations of insulin therapy. However, she responded very well to a unconventional use of the combination of two basal insulin analogs with additional short-acting insulin. This approach needs confirmation and elucidation for a potential role in these not very uncommon cases.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
